Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
:KVUE
KVUE Stock Chart & Stats
$15.08
-$0.04(-0.19%)
At close: 4:00 PM EST
$15.08
-$0.04(-0.19%)
Day’s Range― - ―
52-Week Range$14.05 - $25.17
Previous CloseN/A
Volume2.33M
Average Volume (3M)36.05M
Market Cap
$28.79B
Enterprise ValueN/A
Total Cash (Recent Filing)$1.07B
Total Debt (Recent Filing)$8.74B
Price to Earnings (P/E)20.4
Beta0.23
Next Earnings
Nov 06, 2025EPS Estimate
0.26Last Dividend Ex-Date
Aug 13, 2025Dividend Yield5.45%
Share Statistics
EPS (TTM)0.29
Shares Outstanding1,919,070,000
10 Day Avg. Volume31,607,820
30 Day Avg. Volume36,046,576
Financial Highlights & Ratios
PEG Ratio-0.98
Price to Book (P/B)4.20
Price to Sales (P/S)2.62
P/FCF Ratio30.38
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$19.91Price Target Upside32.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Bears Say
Financial RiskWhile the ultimate size of the liability for the UK lawsuit remains unknown, there is caution about the financial implications for Kenvue given the legal precedent from the US cases.
Legal IssuesA joint legal claim was filed in the UK seeking over $1.3 billion from Kenvue, alleging they sold contaminated baby powder.
Product Safety ConcernsThe Trump administration announced it is strongly discouraging pregnant women from taking acetaminophen and urged parents to not give it to babies, which could affect Tylenol consumption.
Kenvue, Inc. News
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $14.05 and its highest was $25.17 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $28.79B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Nov 06, 2025 which is in 8 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Jul 14, 2025. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.282 by $0.008.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.207 which represents an annual dividend yield of 5.45%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.26.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,919,070,000 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.29 in its last earnings report, beating expectations of $0.282. Following the earnings report the stock price went up 2.223%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
Kenvue, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$19.91 (32.03% Upside)
$19.91 (32.03% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 32.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▲ 23.2%
Last 30 Days ▲ 23.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.89%
12-Months-Change
Fundamentals
Return on Equity
13.56%
Trailing 12-Months
Asset Growth
2.61%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue, Inc. (KVUE) is a leading consumer health company that specializes in providing a wide range of over-the-counter (OTC) products and health solutions. Operating in sectors such as personal care, wellness, and hygiene, Kenvue's core offerings include well-known brands in pain relief, skin and hair care, oral health, and baby care. The company focuses on delivering innovative and high-quality products that enhance consumer health and well-being.
KVUE Revenue Breakdown
42.23% Self Care
30.33% Essential Health
27.43% Skin Health and Beauty
KVUE Stock 12 Month Forecast
Average Price Target
$19.91
▲(32.03% Upside)
Technical Analysis
Ownership Overview
1.13% Insiders
32.96% Mutual Funds
0.54% Other Institutional Investors
36.08% Public Companies and Individual Investors